Status:
TERMINATED
Treatment of Microscopic Colitis
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
AstraZeneca
Conditions:
Colitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study compares the effect of Budesonide, Bismuth and fiber in patients with microscopic colitis
Detailed Description
This randomized, controlled, open study compares the effects of 8 weeks' treatment with Budesonide, Bismuth and fiber on symptoms and histological findings in patients with microscopic colitis (both c...
Eligibility Criteria
Inclusion
- Microscopic colitis verified with biopsies from the colon
- Symptoms to such an extent that treatment is indicated
- Age \> 17 years
- Informed consent
Exclusion
- Previous treatment with any of the investigational drugs
- Patients treated with ketoconazole
- Pregnant and breast-feeding females
Key Trial Info
Start Date :
November 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT00184171
Start Date
November 1 2001
End Date
October 1 2014
Last Update
January 21 2015
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Aust-Agder Sentralsjukehus
Arendal, Norway
2
Sykehuset Innlandet HF, Gjøvik
Gjøvik, Norway, 2819
3
Sykehuset Innlandet, HF, Hamar
Hamar, Norway
4
Sykehuset Innlandet HF, Lillehammer
Lillehammer, Norway